Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Total Non-Current Liabilities of $27.6 million in Q1 2026, up 24.62% quarter-over-quarter from $22.1 million in Q4 2025, and up 37.32% on a YoY basis from $20.1 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $27.6 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 37.32% year-over-year to $27.6 million; the TTM figure through Mar 2026 stood at $27.6 million (up 37.32% YoY), while the FY2025 annual figure was $22.1 million, up 59.01% from the prior year.
- Total Non-Current Liabilities was $27.6 million for Q1 2026 at Ascend Wellness Holdings, up from $22.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $717.5 million in Q2 2023 to a low of $9.3 million in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $122.4 million across 5 years, with a median of $21.3 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities soared 523.93% in 2023, then plunged 98.69% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $113.3 million in 2022, then sank by 91.6% to $9.5 million in 2023, then jumped by 46.3% to $13.9 million in 2024, then surged by 59.01% to $22.1 million in 2025, then climbed by 24.62% to $27.6 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $27.6 million (Q1 2026), $22.1 million (Q4 2025), and $26.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 27.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.59 Mn |
| Dec 31, 2025 | 22.14 Mn |
| Sep 30, 2025 | 26.42 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Mar 31, 2025 | 20.09 Mn |
| Dec 31, 2024 | 13.92 Mn |
| Sep 30, 2024 | 13.42 Mn |
| Jun 30, 2024 | 11.85 Mn |
| Mar 31, 2024 | 9.28 Mn |
| Dec 31, 2023 | 9.52 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 717.54 Mn |
| Mar 31, 2023 | 705.56 Mn |
| Sep 30, 2022 | 113.26 Mn |
| Jun 30, 2022 | 115.00 Mn |
| Dec 31, 2021 | 126.40 Mn |